Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New EFPIA Head Sought As Bergström Decides To Seek Fresh Pastures

Executive Summary

The Swedish head of the European Federation of Pharmaceutical Industries and Associations is moving on after five years as EFPIA director general, but will stay at the helm to help find his successor.

You may also be interested in...



O’Neill Optimistic Global AMR Review Won’t Lose Steam

Jim O'Neill says he spends sleepless nights worrying whether his Review of Antimicrobial Resistance (AMR) will run out of steam once completed in two months' time - but he's encouraged by growing evidence world leaders and the pharma industry are seriously embracing the theme and will soon make lasting commitments to effectively combat antibiotic resistance, including in Asia.

Friends Or Foes? The Changing Regulator/Industry Relationship In Europe

Top leaders discuss the evolving concept of transparency, more proactive risk management, and industry/regulator interactions at a conference marking 50 years of the EU pharmaceutical legislation.

Richard Bergström confirmed as EFPIA's new DG

Richard Bergström, the head of Sweden's pharmaceutical industry association, LIF, will be the new director general of EFPIA, the European pharmaceutical industry federation.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC097220

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel